Carcinoembryonic antigen-related cell adhesion molecule 1
Homo sapiens
State in the Current Structure
| Assembly | Oligomeric State | Construct | Mutations and Modifications | Ligands, Ions and Associated Components | Method and Experimental Conditions | Structure Quality |
|---|---|---|---|---|---|---|
| 1 | Protein heterocomplex Heteromer Protein × 2 PDB declaration: dimeric(2) Consistent with protein copy count | Chain A; UniProt 34–141 | Not recorded | IgA FC receptor × 1 (P27951) SO4 SULFATE ION × 4 GOL GLYCEROL × 2 | X-RAY DIFFRACTION X-ray crystallization conditions:VAPOR DIFFUSION, HANGING DROP;pH 5.5;293 K;1.7M Ammonium Sulfate, 0.1M Sodium Citrate, pH 5.5 | Resolution 3.25 Å R-free 0.244 |
| 2 | Protein heterocomplex Heteromer Protein × 2 PDB declaration: dimeric(2) Consistent with protein copy count | Chain B; UniProt 34–141 | Not recorded | IgA FC receptor × 1 (P27951) SO4 SULFATE ION × 1 | X-RAY DIFFRACTION X-ray crystallization conditions:VAPOR DIFFUSION, HANGING DROP;pH 5.5;293 K;1.7M Ammonium Sulfate, 0.1M Sodium Citrate, pH 5.5 | Resolution 3.25 Å R-free 0.244 |
Other States of the Same Protein in the Database
Each row is a biological assembly of the same UniProt protein in another PDB entry. The “Difference from current entry” column identifies evidence-level differences; no tag means the currently parsed fields agree.
| Other PDB | Difference from Current Entry 6V3P | Assembly / Oligomeric State | Construct | Mutations and Modifications | Ligands, Ions and Non-polymers | Method and Experimental Conditions | Structure Quality |
|---|---|---|---|---|---|---|---|
| 2GK2 Crystal structure of the N terminal domain of human CEACAM1 Deposited 2006-03-31 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
34–141(108 aa)
Fragment:N terminal domain (residues 63-170)
|
Not recorded | NI NICKEL (II) ION × 1 GOL GLYCEROL × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8.5;294 K;16% (w/v) polyethylene glycol mono methyl ether 2000, 100 mM Tris, and 5 mM nickel chloride, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 294K
|
Resolution 2.20 Å R-free 0.258 |
| 2GK2 Crystal structure of the N terminal domain of human CEACAM1 Deposited 2006-03-31 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain B
34–141(108 aa)
Fragment:N terminal domain (residues 63-170)
|
Not recorded | NI NICKEL (II) ION × 1 GOL GLYCEROL × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8.5;294 K;16% (w/v) polyethylene glycol mono methyl ether 2000, 100 mM Tris, and 5 mM nickel chloride, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 294K
|
Resolution 2.20 Å R-free 0.258 |
| 2GK2 Crystal structure of the N terminal domain of human CEACAM1 Deposited 2006-03-31 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 3 Protein homooligomer Homooligomer;Protein × 6 PDB declaration: hexameric |
Chain A
34–141(108 aa)
Fragment:N terminal domain (residues 63-170)
Chain B
34–141(108 aa)
Fragment:N terminal domain (residues 63-170)
|
Not recorded | NI NICKEL (II) ION × 6 GOL GLYCEROL × 9 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8.5;294 K;16% (w/v) polyethylene glycol mono methyl ether 2000, 100 mM Tris, and 5 mM nickel chloride, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 294K
|
Resolution 2.20 Å R-free 0.258 |
| 2GK2 Crystal structure of the N terminal domain of human CEACAM1 Deposited 2006-03-31 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 4 Protein homooligomer Homooligomer;Protein × 6 PDB declaration: hexameric |
Chain A
34–141(108 aa)
Fragment:N terminal domain (residues 63-170)
Chain B
34–141(108 aa)
Fragment:N terminal domain (residues 63-170)
|
Not recorded | NI NICKEL (II) ION × 6 GOL GLYCEROL × 9 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8.5;294 K;16% (w/v) polyethylene glycol mono methyl ether 2000, 100 mM Tris, and 5 mM nickel chloride, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 294K
|
Resolution 2.20 Å R-free 0.258 |
| 2GK2 Crystal structure of the N terminal domain of human CEACAM1 Deposited 2006-03-31 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 5 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric |
Chain A
34–141(108 aa)
Fragment:N terminal domain (residues 63-170)
Chain B
34–141(108 aa)
Fragment:N terminal domain (residues 63-170)
|
Not recorded | NI NICKEL (II) ION × 2 GOL GLYCEROL × 3 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8.5;294 K;16% (w/v) polyethylene glycol mono methyl ether 2000, 100 mM Tris, and 5 mM nickel chloride, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 294K
|
Resolution 2.20 Å R-free 0.258 |
| 4QXW Crystal structure of the human CEACAM1 membrane distal amino terminal (N)-domain Deposited 2014-07-22 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric |
Chain A
35–141(107 aa)
Fragment:N terminal domain
Chain B
35–141(107 aa)
Fragment:N terminal domain
|
Not recorded | MLA MALONIC ACID × 1 BOG octyl beta-D-glucopyranoside × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8;298 K;50 mM TrisHCL buffer 7.5, 60% Tascimate 8.0, 1% Beta-octyl glucoside, 12% Glycerol, VAPOR DIFFUSION, SITTING DROP, temperature 298K
|
Resolution 2.04 Å R-free 0.242 |
| 4WHD Human CEACAM1 N-domain homodimer Deposited 2014-09-22 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric |
Chain A
34–141(108 aa)
Fragment:N-domain (UNP residues 34-141)
Chain B
34–141(108 aa)
Fragment:N-domain (UNP residues 34-141)
|
Not recorded | BOG octyl beta-D-glucopyranoside × 8 GOL GLYCEROL × 3 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.2;295 K;PEG 3000, NaCl, Phosphate-Citrate
|
Resolution 2.50 Å R-free 0.226 |
| 5DZL Crystal structure of the protein human CEACAM1 Deposited 2015-09-25 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric |
Chain A
35–141(107 aa)
Chain B
35–141(107 aa)
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8;298 K;100 mM Tris 8.0, 25% PEG 3350, 12% glycerol, VAPOR DIFFUSION, SITTING DROP, temperature 298K
|
Resolution 3.40 Å R-free 0.288 |
| 5DZL Crystal structure of the protein human CEACAM1 Deposited 2015-09-25 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric |
Chain C
35–141(107 aa)
Chain D
35–141(107 aa)
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8;298 K;100 mM Tris 8.0, 25% PEG 3350, 12% glycerol, VAPOR DIFFUSION, SITTING DROP, temperature 298K
|
Resolution 3.40 Å R-free 0.288 |
| 6AW2 Crystal structure of the HopQ-CEACAM1 complex Deposited 2017-09-05 | Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain A
34–141(108 aa)
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.5;298 K;20% PEG 6000, 0.1M HEPES , pH 7.5, 0.2M NaCl
|
Resolution 2.68 Å R-free 0.277 |
| 6GBG Helicobacter pylori adhesin HopQ type I bound to the N-terminal domain of human CEACAM1 Deposited 2018-04-13 | Different construct Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain D
35–142(108 aa)
|
Not recorded | BR BROMIDE ION × 3 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.5;293 K;Condition B3 of the Morpheus HT-96 screen (Molecular Dimensions)(0.09 M Halogens mix (0.3M Sodium fluoride; 0.3M Sodium bromide; 0.3M Sodium iodide), 0.1 M Buffer System 1 (1.0M Imidazole; MES monohydrate (acid); pH 6.5), 50 % v/v Precipitant Mix 3 (40% v/v Glycerol; 20% w/v PEG 4000)
|
Resolution 2.80 Å R-free 0.263 |
| 6GBH Helicobacter pylori adhesin HopQ type II bound to the N-terminal domain of human CEACAM1 Deposited 2018-04-13 | Different construct Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain B
35–142(108 aa)
|
Not recorded | SO4 SULFATE ION × 4 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8.5;293 K;Condition A4 of the JB Screen Classic HTS II screen (Jena Bioscience) (1 M Ammonium sulfate, 100 mM Tris; pH 8.5)
|
Resolution 2.59 Å R-free 0.274 |
| 6GBH Helicobacter pylori adhesin HopQ type II bound to the N-terminal domain of human CEACAM1 Deposited 2018-04-13 | Different construct Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain D
35–142(108 aa)
|
Not recorded | SO4 SULFATE ION × 4 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8.5;293 K;Condition A4 of the JB Screen Classic HTS II screen (Jena Bioscience) (1 M Ammonium sulfate, 100 mM Tris; pH 8.5)
|
Resolution 2.59 Å R-free 0.274 |
| 6XNO Crystal structure of E99A mutant of human CEACAM1 Deposited 2020-07-03 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric |
Chain A
35–141(107 aa)
Chain B
35–141(107 aa)
|
Mutation:E99A Mutation:E99A | BOG octyl beta-D-glucopyranoside × 2 MLA MALONIC ACID × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8;298 K;41% Tascimate with 0.5 % n-Octyl-D-glucoside pH 8.0
|
Resolution 1.90 Å R-free 0.223 |
| 6XNT Crystal structure of I91A mutant of human CEACAM1 Deposited 2020-07-04 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric |
Chain A
35–141(107 aa)
Chain B
35–141(107 aa)
|
Mutation:I91A Mutation:I91A | BOG octyl beta-D-glucopyranoside × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8;298 K;54% Tascimate with 0.5 % n-Octyl-D-glucoside pH 8.0
|
Resolution 3.10 Å R-free 0.258 |
| 6XNW Crystal structure of V39A mutant of human CEACAM1 Deposited 2020-07-04 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric |
Chain A
35–141(107 aa)
Chain B
35–141(107 aa)
|
Mutation:V39A Mutation:V39A | NI NICKEL (II) ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7.5;298 K;0.005 M Cobalt(II) chloride hexahydrate, 0.005 M Nickel(II) chloride hexahydrate, 0.005 M Cadmium chloride hydrate, 0.005 M Magnesium chloride hexahydrate with 12% w/v Polyethylene glycol 3,350 in 0.1 M HEPES pH 7.5 buffer
|
Resolution 1.90 Å R-free 0.186 |
| 6XNW Crystal structure of V39A mutant of human CEACAM1 Deposited 2020-07-04 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric |
Chain C
35–141(107 aa)
Chain D
35–141(107 aa)
|
Mutation:V39A Mutation:V39A | NI NICKEL (II) ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7.5;298 K;0.005 M Cobalt(II) chloride hexahydrate, 0.005 M Nickel(II) chloride hexahydrate, 0.005 M Cadmium chloride hydrate, 0.005 M Magnesium chloride hexahydrate with 12% w/v Polyethylene glycol 3,350 in 0.1 M HEPES pH 7.5 buffer
|
Resolution 1.90 Å R-free 0.186 |
| 6XO1 Crystal structure of N97A mutant of human CEACAM1 Deposited 2020-07-05 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
35–141(107 aa)
|
Mutation:N97A | MLA MALONIC ACID × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6;298 K;6% Tascimate with 25% polyethylene glycol 400 in 0.1 M MES monohydrate pH 6.0
|
Resolution 1.76 Å R-free 0.240 |
| 6XO1 Crystal structure of N97A mutant of human CEACAM1 Deposited 2020-07-05 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain B
35–141(107 aa)
|
Mutation:N97A | MLA MALONIC ACID × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6;298 K;6% Tascimate with 25% polyethylene glycol 400 in 0.1 M MES monohydrate pH 6.0
|
Resolution 1.76 Å R-free 0.240 |
| 7MU8 Structure of the minimally glycosylated human CEACAM1 N-terminal domain Deposited 2021-05-14 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric |
Chain A
35–141(107 aa)
Chain B
35–141(107 aa)
|
Not recorded | NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 3 GOL GLYCEROL × 10 SO4 SULFATE ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.5;291 K;100 mM MES, pH 6.5,
2M Ammonium sulfate
|
Resolution 1.70 Å R-free 0.217 |
| 7RPP Crystal structure of human CEACAM1 with GFCC' and ABED face Deposited 2021-08-04 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric |
Chain A
35–141(107 aa)
|
Not recorded | EDO 1,2-ETHANEDIOL × 4 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7.5;298 K;0.2 M Ammonium sulfate, 0.1 M HEPES pH 7.5, 25% w/v Polyethylene glycol 3,350
|
Resolution 2.20 Å R-free 0.237 |
| 7RPP Crystal structure of human CEACAM1 with GFCC' and ABED face Deposited 2021-08-04 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric |
Chain B
35–141(107 aa)
Chain C
35–141(107 aa)
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7.5;298 K;0.2 M Ammonium sulfate, 0.1 M HEPES pH 7.5, 25% w/v Polyethylene glycol 3,350
|
Resolution 2.20 Å R-free 0.237 |
| 8CXJ The IgI3 domain of R28 protein from S. pyogenes bound to CEACAM1 Deposited 2022-05-21 | Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain A
34–141(108 aa)
|
Not recorded | GOL GLYCEROL × 2 SO4 SULFATE ION × 4 CL CHLORIDE ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5.5;293 K;1.45 M Ammonium sulfate
0.1M Na/K Phosphate pH 5.5
|
Resolution 3.05 Å R-free 0.238 |
| 8CXJ The IgI3 domain of R28 protein from S. pyogenes bound to CEACAM1 Deposited 2022-05-21 | Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain C
34–141(108 aa)
|
Not recorded | GOL GLYCEROL × 2 SO4 SULFATE ION × 4 CL CHLORIDE ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5.5;293 K;1.45 M Ammonium sulfate
0.1M Na/K Phosphate pH 5.5
|
Resolution 3.05 Å R-free 0.238 |
| 8CXJ The IgI3 domain of R28 protein from S. pyogenes bound to CEACAM1 Deposited 2022-05-21 | Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 3 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain E
34–141(108 aa)
|
Not recorded | GOL GLYCEROL × 1 SO4 SULFATE ION × 4 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5.5;293 K;1.45 M Ammonium sulfate
0.1M Na/K Phosphate pH 5.5
|
Resolution 3.05 Å R-free 0.238 |
| 8CXJ The IgI3 domain of R28 protein from S. pyogenes bound to CEACAM1 Deposited 2022-05-21 | Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 4 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain G
34–141(108 aa)
|
Not recorded | SO4 SULFATE ION × 2 CL CHLORIDE ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5.5;293 K;1.45 M Ammonium sulfate
0.1M Na/K Phosphate pH 5.5
|
Resolution 3.05 Å R-free 0.238 |
| 9GH5 Complex of Fusobacterium nucleatum CbpF with human CEACAM1 Deposited 2024-08-15 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 6 PDB declaration: hexameric |
Chain D
35–428(394 aa)
Chain E
35–428(394 aa)
Chain F
35–428(394 aa)
|
Not recorded | NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 18 |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.70 Å |
| 9GH6 CEACAM1 (35-234), focused refinement in the complex with CbpF Deposited 2024-08-15 | Different construct Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain D
1–428(428 aa)
|
Not recorded | NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 7 |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.00 Å |
| 9U94 Cryo-EM structure of Fusobacterium nucleatum CbpF in complex with human CEACAM1 Deposited 2025-03-27 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 6 PDB declaration: hexameric |
Chain D
35–141(107 aa)
Chain E
35–141(107 aa)
Chain F
35–141(107 aa)
|
Not recorded | No recorded non-water small molecule |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.11 Å |
17 other PDB entries and 29 assemblies. Open the comparison page and filter oligomeric states
View Construct and Data Evidence
| UniProt name | CEAM1_HUMAN |
| Isoform | P13688-11 |
| PDB entities | 1 |
| Chains and sequence ranges | Author chain A; PDBConstruct 2–109; UniProt 34–141 Author chain B; PDBConstruct 2–109; UniProt 34–141 |